Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences
" "
Safety Alerts
August 4, 1999

SmithKline Beecham Recalls Requip® Tablets

Philadelphia, PA (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that SmithKline Beecham Pharmaceuticals is recalling Requip® Tablets because the tablet fades from pale blue to white.

PRODUCT
Requip® Tablets (Ropinirole HCl), 5 mg, in 100 tablet bottles, Rx taken orally for the treatment of Parkinson's disease. NDC #0007-4894-20.

Recall #D-293-9.

CODE
Lot Numbers: 680930 EXP 4/30/99, 680940 EXP 7/31/99,720510 EXP 11/30/99.

MANUFACTURER
SmithKline Beecham Pharmaceuticals, Crawlely, West Sussex.

RECALLED BY
SmithKline Beecham Pharmaceuticals, Philadelphia, Pennsylvania, by letter sent on March 3, 1999, and June 4, 1999. Firm-initiated recall ongoing.

DISTRIBUTION
Nationwide.

QUANTITY
Approximately 14,033 bottles remained on market at time of recall initiation.

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.